Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1/2 1

Status

Completed 2Withdrawn 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 9Gastrointestinal 3Breast 3Dermatologic 2Tumor-Agnostic 1Thoracic 1Sarcoma 1Lymphoid 1Head & Neck 1Gynecologic 1CNS 1

Conditions

Pancreatic Neoplasms 2Rectal Neoplasms 1Neoplasm Metastasis 1Colorectal Neoplasms 1Colonic Neoplasms 1

Interventions

Oxaliplatin 1004Fluorouracil 800Capecitabine 764Gemcitabine 650Leucovorin 559Irinotecan 537Bevacizumab 513Radiotherapy 460Cisplatin 440Drug Therapy 298Cetuximab 280Surgical Procedures, Operative 229Paclitaxel 228S 1 (combination) 217pembrolizumab 205Docetaxel 199130-nm albumin-bound paclitaxel 196Nivolumab 193sintilimab 191Radiosurgery 190lenvatinib 180Folfox protocol 179Sorafenib 178Albumin-Bound Paclitaxel 173apatinib 170tislelizumab 161camrelizumab 160Neoadjuvant Therapy 158Blood Specimen Collection 154durvalumab 148

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Genistein × Gastrointestinal × Clear all
NCT00376948 2021-03-01

Genistein, Gemcitabine, and Erlotinib in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

Barbara Ann Karmanos Cancer Institute

Phase 2 Completed
20 enrolled 11 charts
Gastrointestinal

Pancreatic Neoplasms

NCT00882765 2020-07-31

Genistein in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery

Jonsson Comprehensive Cancer Center

Phase 2 Withdrawn
Gastrointestinal

Pancreatic Neoplasms

NCT01985763 2019-05-10

Genistein in Treatment of Metastatic Colorectal Cancer

Icahn School of Medicine at Mount Sinai

Phase 1/2 Completed
13 enrolled 17 charts
Gastrointestinal

Colonic Neoplasms, Neoplasm Metastasis, Rectal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡